ONEQ vs. ABBV

Last updated Jun 9, 2026

ONEQ (Fidelity Nasdaq Composite Index ETF) is Large Cap Growth Equities fund tracking the Nasdaq Composite Index, while ABBV (AbbVie Inc.) is a stock. Over the past 10 years, ONEQ returned 19.36%/yr vs 18.63%/yr for ABBV. At a 0.33 correlation, their price movements are largely independent.

Performance

ONEQ vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Nasdaq Composite Index ETF (ONEQ) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ONEQ achieves a 12.15% return, which is significantly higher than ABBV's -0.77% return. Both investments have delivered pretty close results over the past 10 years, with ONEQ having a 19.36% annualized return and ABBV not far behind at 18.63%.

ONEQ

• 1D: 0.83%
• 1M: -1.13%
• YTD: 12.15%
• 6M: 10.74%
• 1Y: 33.89%
• 3Y*: 26.07%
• 5Y*: 14.42%
• 10Y*: 19.36%

ABBV

• 1D: -1.83%
• 1M: 10.68%
• YTD: -0.77%
• 6M: 1.62%
• 1Y: 21.34%
• 3Y*: 21.59%
• 5Y*: 18.74%
• 10Y*: 18.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ONEQ vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ONEQ Fidelity Nasdaq Composite Index ETF	12.15%	20.89%	29.30%	45.73%	-32.12%	22.11%	44.87%	38.01%	-3.18%	29.29%
ABBV AbbVie Inc.	-0.77%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Correlation

The correlation between ONEQ and ABBV is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (10Y) Calculated over the trailing 10-year period	0.27
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.33

The correlation between ONEQ and ABBV shifts across timeframes, from -0.06 (1 year) to 0.33 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ONEQ vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ONEQ

ONEQ Risk / Return Rank: 65
ONEQ Sharpe Ratio Rank: 70
ONEQ Sortino Ratio Rank: 65
ONEQ Omega Ratio Rank: 67
ONEQ Calmar Ratio Rank: 60
ONEQ Martin Ratio Rank: 64

ABBV

ABBV Risk / Return Rank: 66
ABBV Sharpe Ratio Rank: 70
ABBV Sortino Ratio Rank: 64
ABBV Omega Ratio Rank: 62
ABBV Calmar Ratio Rank: 66
ABBV Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ONEQ vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Nasdaq Composite Index ETF (ONEQ) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ONEQ	ABBV	Difference
Sharpe ratio: Return per unit of total volatility	2.06	0.88	+1.17
Sortino ratio: Return per unit of downside risk	2.68	1.37	+1.31
Omega ratio: Gain probability vs. loss probability	1.36	1.17	+0.19
Calmar ratio: Return relative to maximum drawdown	2.69	1.24	+1.46
Martin ratio: Return relative to average drawdown	10.57	2.77	+7.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ONEQ vs. ABBV - Sharpe Ratio Comparison

The current ONEQ Sharpe Ratio is 2.06, which is higher than the ABBV Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of ONEQ and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ONEQ	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.06	0.88	+1.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.65	0.82	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.89	0.73	+0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.64	0.74	-0.10

Drawdowns

ONEQ vs. ABBV - Drawdown Comparison

The maximum ONEQ drawdown since its inception was -55.09%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ONEQ and ABBV.

Drawdown Indicators

	ONEQ	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-55.09%	-45.09%	-10.00%
Max Drawdown (1Y) Largest decline over 1 year	-12.64%	-17.32%	+4.68%
Max Drawdown (3Y) Largest decline over 3 years	-24.09%	-20.74%	-3.35%
Max Drawdown (5Y) Largest decline over 5 years	-35.23%	-21.92%	-13.31%
Max Drawdown (10Y) Largest decline over 10 years	-35.23%	-45.09%	+9.86%
Current Drawdown Current decline from peak	-4.27%	-6.55%	+2.28%
Average Drawdown Average peak-to-trough decline	-7.95%	-10.72%	+2.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.22%	7.72%	-4.50%

Volatility

ONEQ vs. ABBV - Volatility Comparison

The current volatility for Fidelity Nasdaq Composite Index ETF (ONEQ) is 5.86%, while AbbVie Inc. (ABBV) has a volatility of 6.39%. This indicates that ONEQ experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ONEQ	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.86%	6.39%	-0.53%
Volatility (6M) Calculated over the trailing 6-month period	12.74%	17.89%	-5.15%
Volatility (1Y) Calculated over the trailing 1-year period	16.58%	24.33%	-7.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.22%	22.91%	-0.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.76%	25.74%	-3.98%

Dividends

ONEQ vs. ABBV - Dividend Comparison

ONEQ's dividend yield for the trailing twelve months is around 0.69%, less than ABBV's 3.02% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.02%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
ONEQ Fidelity Nasdaq Composite Index ETF	0.69%	0.54%	0.65%	0.71%	0.97%	0.54%	0.71%	2.51%	1.08%	0.84%	1.12%	1.04%

Frequently Asked Questions

Can I hold both ONEQ and ABBV in my portfolio?

ONEQ and ABBV have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ONEQ or ABBV?

ABBV has higher volatility (6.39%) compared to ONEQ (5.86%). In terms of maximum drawdown, ONEQ dropped -55.09% vs ABBV's -45.09%.

Which has better risk-adjusted returns?

ONEQ currently has the higher Sharpe Ratio (2.06 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.